Literature DB >> 19004964

Age, comorbidity, treatment decision and prognosis in lung cancer.

José Antonio Gullón Blanco1, Isabel Suárez Toste, Ramón Fernández Alvarez, Gemma Rubinos Cuadrado, Agustín Medina Gonzalvez, Isidro Jesús González Martín.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19004964     DOI: 10.1093/ageing/afn226

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  19 in total

1.  Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.

Authors:  L Decoster; C Kenis; D Schallier; J Vansteenkiste; K Nackaerts; L Vanacker; N Vandewalle; J Flamaing; J P Lobelle; K Milisen; J De Grève; H Wildiers
Journal:  Lung       Date:  2017-06-20       Impact factor: 2.584

Review 2.  Systemic therapies for metastatic renal cell carcinoma in older adults.

Authors:  Sumanta K Pal; Ari Vanderwalde; Arti Hurria; Robert A Figlin
Journal:  Drugs Aging       Date:  2011-08-01       Impact factor: 3.923

3.  Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.

Authors:  Tatiana Akimova; Tianyi Zhang; Dmitri Negorev; Sunil Singhal; Jason Stadanlick; Abhishek Rao; Michael Annunziata; Matthew H Levine; Ulf H Beier; Joshua M Diamond; Jason D Christie; Steven M Albelda; Evgeniy B Eruslanov; Wayne W Hancock
Journal:  JCI Insight       Date:  2017-08-17

4.  Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.

Authors:  Daniel H Ahn; Nishi Mehta; Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber
Journal:  Clin Lung Cancer       Date:  2013-07-22       Impact factor: 4.785

5.  Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.

Authors:  Christina D Williams; Karen M Stechuchak; Leah L Zullig; Dawn Provenzale; Michael J Kelley
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

6.  Completeness of TNM staging of small-cell and non-small-cell lung cancer in the Danish cancer registry, 2004-2009.

Authors:  Thomas Deleuran; Mette Søgaard; Trine Frøslev; Torben Riis Rasmussen; Henrik Kirstein Jensen; Søren Friis; Morten Olsen
Journal:  Clin Epidemiol       Date:  2012-08-17       Impact factor: 4.790

7.  Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality.

Authors:  T L Jørgensen; J Hallas; S Friis; J Herrstedt
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

8.  Analysis of the characteristics and prognosis of advanced non-small-cell lung cancer in older patients.

Authors:  Ying Gao; Fei Gao; Jin-Lu Ma; Xiao-Zhi Zhang; Yi Li; Li-Ping Song; Dong-Li Zhao
Journal:  Patient Prefer Adherence       Date:  2015-08-19       Impact factor: 2.711

9.  The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.

Authors:  T Kalsi; G Babic-Illman; P J Ross; N R Maisey; S Hughes; P Fields; F C Martin; Y Wang; D Harari
Journal:  Br J Cancer       Date:  2015-04-14       Impact factor: 7.640

10.  Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group.

Authors:  H H Strøm; R M Bremnes; S H Sundstrøm; N Helbekkmo; O Fløtten; U Aasebø
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.